Prevalence and risk factors for antimalarial drugs induced maculopathy in Phra Nakhon Si Ayutthaya Hospital

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20260801003

Enrollment

176

Registered

2026-08-01

Start date

2025-10-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

antimalarial drugs induced maculopathy in rheumatic patients antimalarial, chloroquine, hydroxychloroquine, maculopathy

Interventions

patients diagnosed with antimalarial maculopathy,patients with no evidence of antimalarial-induced retinopathy

Prevention,Prevention

maculopathy,non maculopathy

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Rheumatic patients aged 18 and older who have been on antimalarial drugs for over a year

Exclusion criteria

Exclusion criteria: Patients who have not been evaluated by an ophthalmologist

Design outcomes

Primary

Measure	Time frame
Prevalence and risk factors for antimalarial drugs induced maculopathy 1 years meta analysis logistic regression	—

Secondary

Measure	Time frame
antimalarial drugs induced maculopathy 1 year Observe Data Record	—

Countries

Thailand

Contacts

Public ContactRungkan Ruksasakul

Internal Medicine, Phra Nakhon Si Ayutthaya Hospital

tongkatongka@hotmail.com035211888

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026